This activity explores practical considerations around using medications as an adjunct to healthy behaviour change in the long-term management of overweight and obesity.
Almost two thirds of adults in Australia live with overweight or obesity, and excess weight is the second leading contributor to Australia’s health burden. Lifestyle and behavioural interventions are the cornerstone of treatment in obesity however only a minority of people experience sustainable, long-term weight loss with those interventions alone. Australian and international obesity management guidelines therefore recommend a multicomponent approach to obesity care that includes pharmacotherapies in selected patients.
Presented by GP Conjoint A/Prof Chee Khoo, this on-demand webinar reviews latest developments in weight loss pharmacotherapy and explores practical considerations around using medications as an adjunct to healthy behaviour change in the long-term management of overweight and obesity.
Learning outcomes
Presenter
A/Prof Chee Khoo is a solo GP in Ingleburn since 1990. He has special interests in chronic disease and primary care education. He is the chair of the Education Working Group at the Diabetes, Obesity and Metabolism Translational Research Unit (DOMTRU).
He is a member of:
–RACGP’s Specific Interest Groups in Diabetes and Obesity Management
–Australian Diabetes Society (ADS)
–Australian Atherosclerosis Society (AAS)
–European Association for the Study of Diabetes (EASD)
–ANZ Society for Sarcopenia and Frailty Research (ANZSSFR)
He is also the Editor-in-Chief at GPVoice.com.au.
